Phase One Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MSP008-22 in Healthy Adult Volunteers
NCT05532293
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
64
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
MSP008-22
OTHER:
Placebo
Sponsor
Godavari Biorefineries Limited